Literature DB >> 15282811

Prebolus quantitative MR heart perfusion imaging.

Herbert Köstler1, Christian Ritter, Michael Lipp, Meinrad Beer, Dietbert Hahn, Jörn Sandstede.   

Abstract

The purpose of this study was to present the prebolus technique for quantitative multislice myocardial perfusion imaging. In quantitative MR perfusion studies the maximum contrast agent dose is limited by the requirement to determine the arterial input function (AIF). The prebolus technique consists of two consecutive contrast agent administrations. The AIF is determined from a first low-dose bolus, while a second, high-dose bolus allows the measurement of the myocardium with improved signal increase. The results of the prebolus technique using a multislice saturation recovery trueFISP sequence in healthy volunteers are presented. In comparison to a standard dose of 3 ml Gd-DTPA, perfusion values are maintained while the signal increase in the concentration time courses was considerably improved, accompanied by reduced standard deviations of the obtained perfusion values (0.72 +/- 0.13 ml/g/min for 1 ml/8 ml and 0.67 +/- 0.10 ml/g/min for 1 ml/12 ml Gd-DTPA, respectively).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282811     DOI: 10.1002/mrm.20160

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  33 in total

Review 1.  Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside.

Authors:  Pierre Croisille; Didier Revel; Maythem Saeed
Journal:  Eur Radiol       Date:  2006-04-22       Impact factor: 5.315

Review 2.  Multicentre imaging measurements for oncology and in the brain.

Authors:  P S Tofts; D J Collins
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Accelerated dual-contrast first-pass perfusion MRI of the mouse heart: development and application to diet-induced obese mice.

Authors:  Nivedita K Naresh; Xiao Chen; Rene J Roy; Patrick F Antkowiak; Brian H Annex; Frederick H Epstein
Journal:  Magn Reson Med       Date:  2014-04-23       Impact factor: 4.668

Review 4.  State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications.

Authors:  Magalie Viallon; Victor Cuvinciuc; Benedicte Delattre; Laura Merlini; Isabelle Barnaure-Nachbar; Seema Toso-Patel; Minerva Becker; Karl-Olof Lovblad; Sven Haller
Journal:  Neuroradiology       Date:  2015-04-10       Impact factor: 2.804

Review 5.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.

Authors:  Michael Ingrisch; Steven Sourbron
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-06       Impact factor: 2.745

6.  Quantitative pixelwise myocardial perfusion maps from first-pass perfusion MRI.

Authors:  A M Weng; C O Ritter; M Beer; D Hahn; H Köstler
Journal:  Br J Radiol       Date:  2014-05-14       Impact factor: 3.039

7.  Automatic postprocessing for the assessment of quantitative human myocardial perfusion using MRI.

Authors:  Andreas Max Weng; Christian Oliver Ritter; Joachim Lotz; Meinrad Joachim Beer; Dietbert Hahn; Herbert Köstler
Journal:  Eur Radiol       Date:  2009-12-17       Impact factor: 5.315

8.  Four-dimensional transcatheter intraarterial perfusion (TRIP)-MRI for monitoring liver tumor embolization in VX2 rabbits.

Authors:  Dingxin Wang; Sumeet Virmani; Richard Tang; Barbara Szolc-Kowalska; Gayle Woloschak; Reed A Omary; Andrew C Larson
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

9.  Myocardial perfusion MRI shows impaired perfusion of the mouse hypertrophic left ventricle.

Authors:  Bastiaan J van Nierop; Bram F Coolen; Noortje A Bax; Wouter J R Dijk; Elza D van Deel; Dirk J Duncker; Klaas Nicolay; Gustav J Strijkers
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-28       Impact factor: 2.357

10.  Quantification of myocardial perfusion using CMR with a radial data acquisition: comparison with a dual-bolus method.

Authors:  Tae Ho Kim; Nathan A Pack; Liyong Chen; Edward V R DiBella
Journal:  J Cardiovasc Magn Reson       Date:  2010-07-23       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.